EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell‐derived factors

Akbar L Marzan, Sai V Chitti, Sriram Gummadi, Taeyoung Kang, Ching-Seng Ang, Suresh Mathivanan iD

PROTEOMICS · 2024-06 · 24 (11)

DOI: 10.1002/pmic.202300020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 26.10.2023. Verfasst von Akbar L Marzan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Proteomics, Muscle Fibers, Skeletal, Muscular Atrophy, Cachexia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Research Council Future Fellowship.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐associated cachexia is a wasting syndrome that results in dramatic loss of whole‐body weight, predominantly due to loss of skeletal muscle mass. It has been established that cachexia inducing cancer cells secrete proteins and extracellular vesicles (EVs) that can induce muscle atrophy. Though several studies examined these cancer‐cell derived factors, targeting some of these components have shown little or no clinical benefit. To develop new therapies, understanding of the dysregulated proteins and signaling pathways that regulate catabolic gene expression during muscle wasting is essential. Here, we sought to examine the effect of conditioned media (CM) that contain secreted factors and EVs from cachexia inducing C26 colon cancer cells on C2C12 myotubes using mass spectrometry‐based label‐free quantitative proteomics. We identified significant changes in the protein profile of C2C12 cells upon exposure to C26‐derived CM. Functional enrichment analysis revealed enrichment of proteins associated with inflammation, mitochondrial dysfunction, muscle catabolism, ROS production, and ER stress in CM treated myotubes. Furthermore, strong downregulation in muscle structural integrity and development and/or regenerative pathways were observed. Together, these enriched proteins in atrophied muscle could be utilized as potential muscle wasting markers and the dysregulated biological processes could be employed for therapeutic benefit in cancer‐induced muscle wasting.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsMuscle Fibers, SkeletalMuscular AtrophyCachexiaAnimalsMiceCell Line, TumorCulture Media, ConditionedExtracellular VesiclesHumansProteome

Stichwörter der Autor:innen

C26 colon carcinomaC2C12 myotubescancer‐associated cachexiaimpaired myogenesismuscle atrophy

Substanzen

Culture Media, ConditionedProteome

Autor:innen und Institutionen

  • Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia.
  • The Bio21 Institute of Molecular Science and Biotechnology Institute, University of Melbourne, Parkville, Victoria, Australia.

ORCID-Profile: Suresh Mathivanan

Förderung

  • Australian Research Council Future Fellowship

Zitieren

APA

Marzan, A. L., Chitti, S. V., Gummadi, S., Kang, T., Ang, C. S., & Mathivanan, S. (2024). Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell‐derived factors. PROTEOMICS, 24(11). https://doi.org/10.1002/pmic.202300020

Vancouver

Marzan AL, Chitti SV, Gummadi S, Kang T, Ang CS, Mathivanan S. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell‐derived factors. PROTEOMICS. 2024;24(11). doi:10.1002/pmic.202300020

BibTeX
@article{Marzan2024,
  author = {Marzan, Akbar L and Chitti, Sai V and Gummadi, Sriram and Kang, Taeyoung and Ang, Ching-Seng and Mathivanan, Suresh},
  title = {Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell‐derived factors},
  journal = {PROTEOMICS},
  year = {2024},
  volume = {24},
  number = {11},
  doi = {10.1002/pmic.202300020}
}
Kostenlos starten →